Tag: Pharming
Pharming Reacquires RUCONEST®-licensed Territories from Sobi

Pharming Reacquires RUCONEST®-licensed Territories from Sobi

- Pharming will take control of commercial rights to its product RUCONEST® in all 36 remaining countries - Pharming will pay a total of EUR7.5 million in two tranches for a ...

Lees verder
Pharming Group Reports Strong Interim Financial Results for the First Nine Months of 2019

Pharming Group Reports Strong Interim Financial Results for the First Nine Months of 2019

LEIDEN, Netherlands, Oct. 24, 2019 /PRNewswire/ -- Compared with the first nine months of 2018 (on a like-for-like basis): -- Revenues up 26%, operating profit up 38%, ...

Lees verder
Pharming Group Reports Strong Financial Results for the First Half of 2019

Pharming Group Reports Strong Financial Results for the First Half of 2019

Delivered 31% increase in revenue, 51% increase in operating profit and 60% increase in net profit year-on-year Delivered 21% increase in revenue, with increases in operating ...

Lees verder
Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study

Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study

LEIDEN, Netherlands, June 11, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") today announces that, following receipt of the Dutch investigating ...

Lees verder
Pharming Announces Agenda for Its Capital Markets Briefing to be Held on 21 June 2018 in New York

Pharming Announces Agenda for Its Capital Markets Briefing to be Held on 21 June 2018 in New York

LEIDEN, Netherlands, June 5, 2018 /PRNewswire/ -- New forms of administration for RUCONEST(R) for HAE   Expansion of rhC1INH clinical development in pre-eclampsia, contrast ...

Lees verder
Pharming Reports on Annual General Meeting of Shareholders

Pharming Reports on Annual General Meeting of Shareholders

LEIDEN, Netherlands, May 23, 2018 /PRNewswire/ -- Mr. Jaap Blaak, Former Chairman of the Board of Supervisory Directors, retires from the Board Pharming Group N.V. ...

Lees verder
Pharming Group Interim Report on Financial Results for the First Quarter 2018

Pharming Group Interim Report on Financial Results for the First Quarter 2018

LEIDEN, Netherlands, May 17, 2018 /PRNewswire/ -- 93% increase in revenues from product sales and 110% increase in operating profit compared with the First Quarter 2017  ...

Lees verder
Pharming Announces Further Conversion of its Ordinary Convertible Bonds

Pharming Announces Further Conversion of its Ordinary Convertible Bonds

LEIDEN, Netherlands, January 4, 2018 /PRNewswire/ -- Bondholders convert EUR7.7 million of their remaining bonds into Pharming Shares and cash  Further reduction in net debt ...

Lees verder
Pharming Announces Positive Data from Paediatric Clinical Trial with RUCONEST®

Pharming Announces Positive Data from Paediatric Clinical Trial with RUCONEST®

LEIDEN, the Netherlands, September 29, 2017 /PRNewswire/ -- RUCONEST(R) provided clinically meaningful relief of symptoms in children with hereditary angioedema  Pharming ...

Lees verder
Pharming Group N.V. and HAEi International Patient Organization Announce Partnership with Inceptua Medicines Access for "HAEi Global Access Progr

Pharming Group N.V. and HAEi International Patient Organization Announce Partnership with Inceptua Medicines Access for "HAEi Global Access Progr

LEIDEN, Netherlands and LUXEMBOURG, September 26, 2017 /PRNewswire/ -- Allows hereditary angioedema (HAE) patients in all countries to gain access to RUCONEST via Medicines ...

Lees verder
BizPress.nl